Additionally, the upregulation of EZH2, as a downstream target of the MEK/ERK/Elk signaling pathway, correlates with invasion, proliferation, and poor prognosis in triple-negative breast cancer [121]. This evidence concerns the gene EZH2 and triple-negative breast carcinoma.